Publications - Associate Professor John Kelly

Peer-Reviewed Publications

2014

Chan M, Kelly J, Batterham M and Tapsell L.A High Prevalence of Abnormal Nutrition Parameters Found in Pre-Dialysis End Stage Kidney Disease: Is it a Result of Uraemia or Poor Eating Habits?J Ren Nutr. 24 (5), 292-302, 2014

 

2008

Kelly JJ. Micronutrient Deficiency in Chronic Kidney Disease. Nephrology (Carlton). 2008; 13(1):1-2.

2007

O’Sullivan AJ, Kelly JJ. Insulin Resistance and Protein catabolism in Non-diabetic hemodialysis patients. Kidney International. 2007. 71 (2): 98 – 100.

Shen YY, Charlesworth JA, Kelly JJ, Loi KW, Peake PW. Upregulation of adiponectin, its isoforms and receptors in end-stage renal disease. Nephrology, Dialysis, Transplantation, 22 (1): 171-178, 2007.

Shen YY, Charlesworth JA, Kelly JJ, Peake PW. The effect of renal transplantation on adiponectin and its isoforms and receptors. Metabolism: Clinical & Experimental. 56(9):1201-8, 2007.

Cheema B, Abas H, Smith B, O'Sullivan A, Chan M, Patwardhan A, Kelly JJ, Gillin A, Pang G, Lloyd B, Fiatarone Singh M. Randomized controlled trial of intradialytic resistance training to target muscle wasting in ESRD: the Progressive Exercise for Anabolism in Kidney Disease (PEAK) study. Am J Kidney Dis. 50(4):574-84, 2007

Kelly JJ, Tam SH. Williamson PM, Whitworth, J A. Decreased threshold for the nitric oxide donor glyceryl trinitrate in cortisol-induced hypertension in humans. Clin Exper Pharmacol Physiol. 34(12):1317-8, 2007 Dec.

Kelly JJ. Renal Vascular Disease in Clinical Cases in Kidney Disease edited by Harris DCH. MCGraw Hill Medical Australia Pty Ltd. 1st edition. 2007.

2006

Cheema BSB, O’Sullivan AJ, Chan M, Patwardhan A, Kelly J, Gillin A, Fiatarone Sinch MA. Progressive resistance training during hemodialysis: Rationale and method of a randomized-controlled trial. Haemodialysis International. 2006. 10: 303-310.

Mangos GJ, Walker BR, Williamson PM, Whitworth JA, Kelly JJ. Effect of synthetic corticosteroids on vascular reactivity in the Human Forearm. Clinical and Experimental Hypertension. 2006, 28: 707-718. 2006

Whitworth JA, Zhang JA, Mangos G, Kelly JJ. Species variability in cardiovascular research: the example of adrenocorticotrophin-induced hypertension. Clin Exper Pharmacol Physiol. 2006, 33(9):887-891

2005

Williamson PM, Kohlhagen J, Mangos G, Whitworth JA, Kelly JJ. Acute effects of hydrocortisone on plasma nitrate/nitrite activity and forearm vasodilator responsiveness in normal human subjects. Clin Exp Pharmacol. Physiol. 2005; 32:162-166.

Williamson PM, Tam SH, Kelly JJ, Whitworth JA. Ganglion blockage dose not prevent cortisol induced hypertension in man. Clin Exp Pharmacol. Physiol 2005; 32: 294-296.

Kennedy S, Shen Y, Charlesworth JA, Mackie JD, Mahony JD, Kelly JJ, Pussell BA. Outcome of overseas commercial kidney transplantation: an Australian perspective. MJA 2005; 182: 224-227.

Kohlhagen J, Kelly JJ. Vascular disease and risk factors in chronic kidney disease. Journal of Vascular Disease Prevention. 2005, 2: 321-331

Shen Y, Peake PW, Kelly JJ. Should we quantify insulin resistance in patients with renal disease. Nephrology. 2005; 10: 599-605.

Kelly J, Stanley M, Harris D. Acceptance onto Dialysis Guidelines. Predialysis education. Nephrology. 2005; 10: S46-S49.

Whitworth JA, Williamson PM, Mangos, G, Kelly JJ. Cardiovascular consequences of cortisol excess. Vascular Health and Risk Management. 2005:1 (4) 291-299

Whitworth JA, Zang Y, Mangos G, Kelly JJ. Species variability in cardiovascular research: the example of adrenocorticotrophin-induced hypertension. Clin Exp Pharmacol. Physiol 33(9):887-91,

2003

Poynten AM, Gan SK, Kriketos AD, O’Sullivan AJ, Kelly JJ, Ellis BA, Chisholm DJ, Campbell LV. Nicotinic acid-induced insulin resistance is related to increased circulating fatty acids and fat oxidation but not muscle lipid content. Metabolism – Clinical and Experimental, 52: 699-704, 2003

Chin-Dusting JPF, Ahlers BA, Kaye DM, Kelly JJ, Whitworth JA. Arginine transport in humans with cortisol-induced hypertension. Hypertension, 41 (6): 1336-1340, 2003.

Mangos GJ, Whitworth JA, Williamson PM, Kelly JJ. Glucocorticoids and the kidney. Nephrology. 2003 (8): 267-273

Kohlhagen J, Kelly JJ. Prevalence of vascular risk factors and vascular disease in chronic renal failure. Nephrology. 2003 (8): 274-279

Gotsopoulos H, Kelly JJ, Cistulli P. Oral Appliance Therapy Reduced Blood Pressure In Obstructive Sleep Apnoea: A Randomised Controlled Trial. Sleep, 2004 ;27:934-941

Kelly JJ, Kohlhagen J. ASFAST - Untangling the web of cardiovascular risk in chronic kidney disease (invited editoral). Nephrology 2004, 9: 112-113.

Whitworth JA, Mangos G, Kelly JJ. Hypertension in Cushing’s Syndrome in Secondary Hypertension, Clinical Presentation and Diagnosis and Treatment edited by George A Mansoor MD 2004. Chapter 5, 195 – 220. 2004 Human Press Inc. Totowa, New Jersey. ISBN 1-58829-141-3

2002

O’Sullivan AJ, Lawson AJ, Chan M, Kelly JJ. Body composition and energy expenditure in chronic renal failure. Am J Kidney Dis. 2002 Feb;39(2):283-90

2001

Lawson JA, Lazarus R, Kelly JJ. Prevalence and prognostic significance of malnutrition in chronic renal failure insufficiency. J Renal Nutrit. 2001; 11:16-22

Kelly JJ, Williamson P, Martin A, Whitworth JA. Effects of oral L-arginine on plasma nitrate and blood pressure in cortisol treated humans. J Hypertens 2001; 19: 263-268.

Whitworth JA. Schyvens CG. Zhang Y. Mangos GJ. Kelly JJ. Glucocorticoid-induced hypertension: from mouse to man Clin Exp Pharmacol. Physiol 28(12):993-6, 2001 Dec.

2000

Kelly JJ, Martin A, Whitworth JA. Role of erythropoietin in cortisol induced hypertension. J Hum Hypertens. 2000; 14: 195-198.

Mangos GJ, Kelly JJ, Whitworth JA. Cortisol and Essential Hypertension. Kidney: A Current Survey of World Literature. 2000;9: 47-50.

Kelly JJ, Lawson JA, Campbell LV, Storlein LH, Jenkins AB, Whitworth JA, O’Sullivan AJ. Effects of nicotinic acid on insulin sensitivity and blood pressure in healthy subjects. J Hum Hypertens. 2000; 14: 567-572.

Laws RA, Tapsell LL, Kelly JJ. Nutritional status and its relationship to quality of life in a sample of haemodialysis patients. J Renal Nutrit. 2000;10:139-147.

Kelly JJ, Whitworth. Involvement of angiotensin II in a hydromineral balance, in Drugs, Receptors and Enzymes of the Renin-angiotens in System: Celebrating a Century of Discovery. Ed: Ahsan Husain and Robert Graham. Harwood Academic Publishers. Amsterdam, The Netherlands. 2000. Vol 1;63-66. ISBN 90-5823-038-4, ISSN 1561-4409.

Kelly JJ, Whitworth JA. Renal Blood Flow in Human Diseases. In "The Renal Circulation". Ed WP Anderson. JAI Press Inc. Advances in Organ Biology. Volume 9, pages 347-368. ISBN: 0-7623-0617-3

Kelly JJ.The CARI Guidelines. Caring for Australians with Renal Impairment. Acceptance onto Dialysis. Guidelines 1 –3, pages 3 –14. Ed: John Knight and Dushyanthi Vimalachandra. Excerpta Medica Communications. 2000.

Mangos GJ, Walker BR, Kelly JJ, Lawson JA, Webb DJ, Whitworth JA. Cortisol inhibits cholinergic vasodilation in the human forearm. Am J Hypertens. 2000; 13: 1155-1160.

Whitworth JA. Mangos GJ. Kelly JJ. Cushing, cortisol, and cardiovascular disease Hypertension. 36(5):912-6, 2000 Nov.

Articles in Medical Publications and Periodicals

Kelly JJ. Nephrotic Syndrome MIMS Disease Index, 3rd Edition, 2006: in press

Kelly JJ. Preventing progression of chronic renal failure. Current Therapeutics. 2001 July 2001: Vol 42: 12-16

Kelly JJ. Case commentary: managing the patient with refractory hypertension. Medicine Today. 2001: Vol 2: 127

Back to Top